Tom Wilton
Corporate Officer/Principal bij CARISMA THERAPEUTICS, INC.
Profiel
Tom Wilton is currently the Chief Business Officer at LogicBio Therapeutics, Inc. and Carisma Therapeutics, Inc. He is a graduate of Brunel University, the University of Leeds, and the University of London.
Actieve functies van Tom Wilton
| Bedrijven | Functie | Begin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2019 |
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Tom Wilton
| University of London | Undergraduate Degree |
| University of Leeds | Graduate Degree |
| Brunel University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
